0.1557
price down icon5.12%   -0.0084
after-market Handel nachbörslich: .16 0.0043 +2.76%
loading

Finanzdaten der Genprex Inc-Aktie (GNPX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
1.59%
2.4995
2.54 2.8385 2.7561 1.6665
Costs And Expenses
17.95%
4.6818
3.9693 4.3357 4.3234 6.5183
Operating Income/Loss
17.95%
-4.6818
-3.9693 -4.3357 -4.3234 -6.5183
Income/Loss From Continuing Operations Before Tax
18.09%
-4.6818
-3.9646 -4.3357 -4.3234 -6.4958
Income/Loss From Continuing Operations After Tax
17.92%
-4.6749
-3.9646 -4.3305 -4.316 -6.4958
Net Income/Loss
17.92%
-4.6749
-3.9646 -4.3305 -4.316 -6.4958
Preferred Stock Dividends And Other Adjustments
-
- 0.2771 - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
80.76%
27.59
15.27 1.5743 3.4998 2.162
Basic Earnings Per Share
34.62%
-0.17
-0.26 1.56 -1.23 -3.00
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- 0.2771 - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):